← Back to ATTO

Attovia Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 02/09/2026Mar 2026Filed 02/09/2026Jun 2025Filed 02/09/2026Mar 2025Filed 02/09/2026
$0.5$0
−$21−$19−$14−$15
−$4.88−$3.71
4.23.9

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.